The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. - Smith,J.W.; Urba,W.J.; Curti,B.D.; Elwood,L.J.; Steis,R.G.; Janik,J.E.; Sharfman,W.H.; Miller,L.L.; Fenton,R.G.; Conlon,K.C. (J Clin Oncol, 1992)